Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dentsply Sirona (XRAY) Share-based Compensation (2016 - 2025)

Dentsply Sirona (XRAY) has disclosed Share-based Compensation for 17 consecutive years, with $8.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Share-based Compensation rose 100.0% year-over-year to $8.0 million, compared with a TTM value of $33.0 million through Dec 2025, down 15.38%, and an annual FY2025 reading of $33.0 million, down 15.38% over the prior year.
  • Share-based Compensation was $8.0 million for Q4 2025 at Dentsply Sirona, up from $6.0 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $22.0 million in Q3 2021 and bottomed at -$6.0 million in Q4 2021.
  • Average Share-based Compensation over 5 years is $11.2 million, with a median of $12.0 million recorded in 2022.
  • The sharpest move saw Share-based Compensation tumbled 154.55% in 2021, then skyrocketed 500.0% in 2024.
  • Year by year, Share-based Compensation stood at -$6.0 million in 2021, then soared by 300.0% to $12.0 million in 2022, then increased by 8.33% to $13.0 million in 2023, then crashed by 69.23% to $4.0 million in 2024, then skyrocketed by 100.0% to $8.0 million in 2025.
  • Business Quant data shows Share-based Compensation for XRAY at $8.0 million in Q4 2025, $6.0 million in Q3 2025, and $9.0 million in Q2 2025.